Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells 23,429 Shares of Stock
MarketBeat
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) CEO Fred Aslan sold 23,429 shares of the company's stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $10.92, for a total value of $255,844.68. Following the completion of the sale, the chief executive officer directly owned 1,449,765 shares in the company, valued at approximately $15,831,433.80. The trade was a 1.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
NASDAQ:ARTV